All Type of News
Health ministry unresponsive to reference pricing system
Despite the state auditors’ recommendation, the ministry of Health, Welfare and Family Affairs intends to reserve the introduction of a reference pricing system.
“The system should be backed by the national consens...
Ilyang announces positive results for ilaprazole in phase 3 study
Ilyang Pharm announced on August 8 that it has completed a multinational Phase 3 clinical study for ilaprozole, a new proton pump inhibitor, in six South East Asian countries including Thailand, Malaysia and Singapore...
Medical representatives mistreated by doctors
A number of medical representatives are annoyed by doctors’ mistreatment in their daily detailing activities to promote ethical products.
They are often complaining about doctors’ negligence and frequent demands fo...
ImQuest receives two-year grant to develop pyrimidinedione product as anti-HIV topical microbicide
Samjin Pharm says that its AIDS treatment co-developer successfully acquired funding from the National Institute of Allergy and Infectious Disease (NIAID/NIH) to support the development of pyrimidinedione inhibitors a...
Pharmaceutical wholesalers urged to seek unity
It is no time for drug wholesalers to remain idle amid negative environments, instead of looking on with folded arms, a senior wholesaler warned.
Critics say the wholesaling industry has left unchanged in a sharp s...
Korea reforms drug re-evaluation system
The government said it has changed the way it handles the drug re-evaluation system from August 8. These include safety and efficacy data from the three-year usage at home as well as that of foreign countries.
The ...
Korea’s regulator supports flexible small-package system
The Korea Food and Drug Administration supports the concept of making the mandatory small-package system operate like a way that drug makers will be allowed to flexibly produce small-package drugs within 10% of the to...
Novartis to conduct additional trial of Rasilez
Novartis Inc. plans to expand the clinical trial program with Rasilez (aliskiren) to study organ protection potential beyond the already shown powerful reduction of blood pressure, according to Novartis Korea.
Rasi...
Taejoon appoints Choo as presidentDr. Choo Sang-un has joined Taejoon Pharm as president effective August 4.
A graduate of Hanyang University’s medical college, Choo has previously held various positions at t...
|
GCC’s OTC products gaining momentum
Green Cross Corp. says its new two products – Hansaplast plaster, first non-medicinal plaster to protect wounds and minor injuries and Taksen, analgesic & anti-inflammatory agent, are expanding market share in the dom...
